Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryAI imaging software company focused on improving MRI and PET image quality and acquisition workflows.
Imaging teams evaluating AI image-enhancement and scan-time workflows rather than diagnostic detection or triage algorithms.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Subtle Medical as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat each Subtle product as a separate imaging device workflow; match clearance, sequence, modality, and intended-use language before changing clinical protocols. |
|---|---|
| Privacy | Verify image transfer, cloud or on-prem processing, retention, DICOM metadata handling, business associate terms, access controls, and vendor security materials. |
| Evidence | Validate image quality, artifact risk, scan-time or dose claims, and radiologist acceptance on local scanner models, protocols, body regions, and patient populations. |
| Workflow | Coordinate radiology, technologist, physicist, PACS, modality, and protocol governance because image-enhancement tools can affect acquisition and interpretation steps. |
Subtle Medical describes AI tools for MRI and PET image quality and acceleration, including SubtleMR, SubtlePET, and the Subtle-ELITE MRI package; company announcements and FDA 510(k) documents should be checked for product-specific clearance and indication details.
Not for: Assuming enhanced images can replace local protocol validation, radiologist quality review, or product-specific clearance checks.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.